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ABSTRACT
Background: Folate has been discussed in relation to fertility among women, but studies on women
under treatment for infertility are lacking.
Objective: The objective of this study was to investigate folic acid supplement use and folate
status among women under treatment for infertility (hereafter infertile) and fertile women also in
regard to socioeconomic and lifestyle factors.
Design: Lifestyle and dietary habits, and use of dietary supplements were assessed using a ques-
tionnaire. Blood samples were obtained for analysis of folate status. 24-hour recall interviews were
also performed.
Results: Highly educated, employed and infertile women were most prone to using folic acid
supplements. The infertile women had a significantly better folate status than the fertile women.
Folate status did not correlate with socioeconomic or lifestyle factors. The infertile women were
physically more active, smoked less and were employed. Our questionnaire data had only fair
agreement with the data from 24-hour recalls, but the folate status data was clearly correlated to
our questionnaire results.
Conclusions: Infertile women were most prone to using folic acid supplements and had better
folate status than the controls. High educational and employment status were found to be key
factors for high compliance to the recommended use folic acid supplements.
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Introduction
It is commonly known that preconceptional folic acid
supplementation prevents neural tube and other birth
defects [1,2]. Therefore, public health authorities all over
Europe, including Sweden, recommend an intake of
400 µg folate per day for women of reproductive age
[1,3]. Despite several public health campaigns and recom-
mendations for over two decades, the compliance to folic
acid supplementation is low in many countries. Results of
previous studies have shown that less than 50% of women
planning a pregnancy use preconceptional folic acid sup-
plementation [4–7]. The current Swedish recommenda-
tion regarding supplement use for those planning a
pregnancy is to take a supplement of 400 µg folic acid
per day, while pregnant or lactating women should aim for
a total of 500 µg per day of folate or folic acid, combining
supplements and folate rich foods [3].
Previous studies of infertile women have shown
that preconceptional folic acid supplementation
increases folate levels and decreases levels of the
amino acid homocysteine (Hcy) in follicular fluid
[8]. In addition, folic acid supplementation has been
related to better embryo quality and chance of preg-
nancy [9], and one study of women taking multi-
vitamins including folic acid showed a reduced risk
of ovulatory infertility [10]. It is known that infer-
tile women use more folic acid supplements than
fertile women, but there is evidence that even
though over 80% of infertile women are aware of
the benefits of using folic acid supplements, only
half actually use them [11,12].
Age, socioeconomic status and educational level
have been related to the awareness and use of folic
acid supplements [13–15]. However, to our knowledge,
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such studies related to infertile women are lacking.
Furthermore, for studies on diet and dietary supple-
ment intake, the method of data collection is of impor-
tance. Most studies have involved the use of
questionnaires for assessment of vitamin intake from
diet alone and information on the intake of dietary
supplements is lacking. Additionally, studies involving
questionnaires for assessing actual intake of supple-
ments have rarely been validated by using alternative
methods such as 24-hour recall interviews [16] and
rarely combined with folate status assessment.
The aim of this study was to investigate folic acid
supplement use and folate status in infertile and fertile
women also in regard to socioeconomic and lifestyle
factors. In addition, a sub-analysis of 24-hour recall
data compared with questionnaire data was performed
to validate the used questionnaire.
Materials and methods
Study subjects and design
In this prospective observational study, women
referred for infertility treatment were recruited.
The women attended the Fertility Unit, Karolinska
University Hospital, Huddinge, Sweden, between
2005 and 2007, or the Centre for Reproduction at
Uppsala University Hospital, Sweden between 2008
and 2010. Healthy, proven fertile, non-pregnant and
non-lactating women from the same geographic
area were randomly recruited as controls.
There were 360 infertile women who agreed to par-
ticipate. Of these women, 340 (94.4%) women com-
pleted the questionnaire. Of the 199 proven fertile
women included in the study, 188 (94.4%) women
completed the questionnaire. In total, 528 women
were included in the final analyses, of which 340 were
women with various infertility diagnoses (Table 1), and
188 were healthy, fertile women in the control group.
Questionnaire
A questionnaire was used to assess socioeconomic
status, health, lifestyle and dietary habits as well as
the use of dietary supplements. The questions
included age, place of birth, marital status,
education and employment status. Self-reported
height and weight were converted to BMI (kg/m2),
and categorized as underweight (< 18.5), normal
weight (18.5–24.9), overweight (25.0–29.9) and
obese (≥ 30). There were also questions about phy-
sical activity and the participants’ perceived subjec-
tive health, as well as smoking habits and
alcohol use.
There were three options as regards the question on
use of dietary supplements: yes, sometimes and no. A
list, containing the 22 most commonly used dietary
supplements in Sweden, was included. An open-
ended question, where the participants could specify
what kind of supplement(s) they used if not on the list,
was included. If taking a folic acid supplement, the
participants answering ‘yes’ or ‘sometimes’ were
recorded as being folic acid supplement users and
they could self-report the amount (µg) of folic acid
ingested. The supplement content of folic acid was
approximated from product information. The mean
value of folic acid intake was calculated if several folic
acid-containing supplements were used alternatively.
24-hour recall
For assessment of dietary folate intake, 24-hour recall
interviews were performed, and these included 103 of
the study subjects. The interviews were performed
twice and only data from women participating in
both interviews were included for further analyses
(n = 91). The subjects were asked to recall in as
much detail as possible what they had been eating
and drinking from the time they woke up the day
before, to 24 hours later. To help estimate portion
sizes, the Swedish Food Administration food model
‘Matmallen’ was used. All information that could pos-
sibly facilitate the registration of data was collected, i.e.
brands, fat content and preparation method. The sub-
jects were also asked to recall supplement intake.
Dietary information from the 24-hour recall interviews
was converted to grams through use of a conversion
table. When brands were indicated, internet sites and/
or telephone numbers for product information served
to assist in obtaining information about food composi-
tion as precisely as possible. The reported food, bev-
erage and dietary supplement intakes were entered in
the dietary analysis program Stor MATs 406 (Rudans
Lättdata, Västerås, Sweden), which uses the Swedish
food composition database (version 02_1; National
Food Administration, Uppsala, Sweden).
To reveal possible under- and over-reporting in 24-hour
recall interviews, the Goldberg cut-off equation was used.
Only normal-reported interviews were included in the
Table 1. Data of infertility diagnoses. Study population
n = 340.
Diagnosis n (%)
Unexplained infertility 180 (52.9)
Male infertility 86 (25.3)
Female infertility 74 (21.8)
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study. Therewere three cases ofmissing data, seven cases of
under-reporting and six cases of over-reporting, resulting
in 75 cases for the final analyses.
Validation of the questionnaire
In order to validate the questionnaire in regards to folic
acid supplement use, the results from two 24-hour recall
interviews on actual supplement use were compared with
the data from questionnaires providing usual supplement
use in 75 cases.
Folate and homocysteine analysis
Blood samples were obtained for assay of plasma folate and
Hcy. After centrifugation, plasma was stored at −70 °C
until analysis. Two-step luminescence competitive analysis
involving folate-binding protein and acridinium ester-
labelled folate was used for assay of folate. Homocysteine
was reduced to nicotinamide adenine dinucleotide, which
was measured at 450 nm. The result was proportional to
the concentration of Hcy. Haemolytic plasma samples or
folate values > 90 nmol/L were excluded because of the risk
ofmisleading values. The reference values for plasma folate
were >8 nmol/L(Architect, ABBOTT) and for plasma
homocysteine < 15 µmol/L [17].
Statistical analysis
Statistical analyses were performed using IBM SPSS
Statistics 20.0 software (IBM Corporation, NY, USA). For
comparisons involving categorical variables, the χ2 test or
Fisher’s exact test (for less than five samples) was applied.
Pearson’s analysis was used to investigate correlation.
Cohen’s kappa coefficient was used to assess differences
in folic acid supplement use when handling data from the
questionnaires and data from the 24-hour recall interviews.
Principal component analysis (PCA) was performed using
SIMCA software (Umetrics, Umeå, Sweden). PCA was
used for analyses of socioeconomic and lifestyle factors.
Results
Folic acid supplement use and folate status in
relation to socioeconomic and lifestyle factors
Among infertile women, folic acid supplement users had a
significantly higher educational level than non-users
(p = 0.037) (Table 2). When comparing folic acid supple-
ment users and non-users in the total population of
women, the folic acid supplement users had higher educa-
tional level (p = 0.017) as well as employment status
(p = 0.026) (Table 2). Not surprisingly, significantly more
infertile women used folic acid supplements (73.2% vs.
39.4%, p < 0.0001), and had significantly higher mean
daily folic acid supplement intake (p < 0.0001) compared
with the fertile women (Table 3). Higher mean dietary
folate intake was also related to folic acid supplement use
in infertile women (p = 0.020) (Table 3). Folic acid supple-
ment use was evidently related to a better folate status
(Table 3). However, Pearson’s correlation analysis did not
show correlations between socioeconomic and lifestyle fac-
tors vs. folate status.
Socioeconomic and lifestyle factors between
infertile and fertile women
Principal component analyses, based on all women,
showed that more highly educated women were physi-
cally more active and consumed more fruit and vege-
tables than women with lower levels of self-perceived
health. The lower educated also had a higher mean
BMI and more often were smokers (data not shown).
When comparing infertile and fertile women, it was
found that the infertile women had a better employ-
ment status (p < 0.0001), exercised more (p = 0.011)
and smoked less (p = 0.012) than the fertile women. It
was also noted that the infertile women were more
often obese than the fertile women (p = 0.020).
Folate intake levels
The mean food folate intake according to the 24-hour
recalls was far lower than the current recommendation,
with means ranging from 140 to 165 ug/day (Table 3).
Previously published data show levels of mean intake
of 223 ± 75 and 247 ± 92 ug/day for 18–30 and 30–44-
year-old women, respectively [18].
Folate status according to plasma folate and
plasma homocysteine levels
Among all women mean plasma folate and plasma
homocysteine levels were within the reference
values (Table 3). Only 14% (n = 68) of women
had plasma folate values under the reference value
(< 8 nmol/L) and 2% (n = 11) had elevated plasma
homocysteine levels (> 15 µmol/L). These levels
were not related to folic acid supplement use or
fertility status (data not shown).
Validation of the questionnaire
To validate the questionnaire, data from 24-hour recall
interviews were compared with data from question-
naires in 75 cases. Cohen’s kappa was 0.37, which was
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considered to represent fair agreement between the
questionnaire results and the 24-hour recall data
regarding folic acid supplement use.
The questionnaire was also tested vs. folate status,
where the folate supplement users according to the
questionnaire had significantly higher folate status
(p < 0.0001) among infertile as well as fertile women
and a lower homocysteine levels (p = 0.004) among the
infertile participants (Table 3).
Discussion
Infertile women were shown to use folic acid supple-
ments to a higher extent in this study. Among fertile as
well as infertile women in this study, high educational
and employment status were found to be key factors
for high compliance of folic acid supplement intake.
Use of folic acid supplements, according to our ques-
tionnaire, also pointed at a better folate status in both
infertile and fertile women. In infertile women, the
supplement use was also associated with a higher
mean dietary folate intake.
Fertility complications [11,19] as well as a higher
socio-economic status [13,14,19–21] have previously
been shown to be associated with more active folic
acid supplement intake, which was also verified in the
current study. In the present study, the infertile women
had significantly higher mean daily folic acid intake
than fertile women. Folic acid supplement users have
previously been shown to have a generally better diet
with higher intake of other dietary components, vita-
mins and minerals compared with non-users [20], a
finding that was confirmed in this study.
It has previously been observed that women who
already have children use fewer dietary supplements,
especially folic acid supplements [5,20]. In the present
study, less than half the studied fertile women took
folic acid supplements and most had folate intakes far
below the recommended. The reason for this might be
that the fertile women were not pregnant or not plan-
ning to become pregnant, and therefore the incentives
to use folic acid supplementation were lacking.
However, it has been shown that approximately half
of all pregnancies are unplanned [22,23], and therefore
the importance of a sufficient intake of folate from
foods or folic acid supplementation should be
considered.
The overall analyses in the present study showed that
physical activity was related to healthy food intake and a
high level of education. When comparing infertile and
fertile women, we found that the infertile women were
physically more active and smoked less. These women
also had better employment status than the fertile
women. Women undergoing fertility treatment are in
many cases well-educated and aware of the possible fac-
tors influencing the outcome of fertility treatment.
Surprisingly, however, obesity, which is known to be
associated with socioeconomic and lifestyle factors as
well as with infertility [24], was more common in the
infertile group. However, in these women obesity might
be seen as a possible cause of infertility rather than
reduction of the chance of a pregnancy.
When investigating diet and dietary supplement intake,
the reliability of reported supplement use is crucial. It has
been suggested that self-administered questionnaires work
well for assessment of regular dietary supplement use [25].
Twenty-four-hour recall interviews allow more specific
description of the actual food intake, while a questionnaire
provides long-term information about usual intake [26].
The questionnaire used in this study showed only fair
agreement (questionnaire vs. interview data) as regards
the use of folic acid supplements. Overestimation of folic
acid supplement use could have occurred in the question-
naire data, something that has been reported previously
[9]. However, the generalizability of this result is limited
since the data was from only 75 women in a sub-analysis.
Table 3. Folic acid (FA) supplement daily intake (according to questionnaire) and daily dietary folate intake (assessed by 24-hour
recalls), and folate status according to plasma folate and plasma homocysteine (Hcy) in infertile and fertile women. Data are shown
as means ± SD.
Infertile Fertile Infertile Fertile
FA
supplement
n = 249
No FA
supplement
n = 89 p-value
FA
supplement
n = 74
No FA
supplement
n = 113 p-value n = 338 n = 187 p-value
FA supplement intake
µg/day
413.97 ± 142.72 - 401.02 ± 136.89 - 298.53 ± 221.91 156.07 ± 213.70 < 0.0001
Dietary folate intake
µg/day
164.93 ± 89.57 139.98 ± 65.63 0.020 150.56 ± 78.35 160.51 ± 74.01 0.382 158.26 ± 84.28 156.70 ± 75.49 0.835
Plasma folate
nmol/L*
26.9 ± 14.2 12.7 ± 6.1 < 0.0001 18.4 ± 10.9 12.6 ± 6.7 < 0.0001 23.2 ± 14.0 14.9 ± 9.0 < 0.0001
Plasma Hcy
µmol/L**
6.6 ± 2.7 7.6 ± 2.3 0.004 8.2 ± 3.6 8.5 ± 3.6 0.653 6.8 ± 2.7 8.4 ± 3.7 < 0.0001
* Reference value P-folate > 8 nmol/L (Architect, ABBOTT).
** Reference value P-Hcy < 15 µmol/L [17].
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A strength of our study lies in the assessment of folate
status as well as folate intake including folic acid intake,
which was calculated from information on dietary sup-
plement use in addition to and not only through infor-
mation on the diet as such. In addition, 24-hour recall
interview data were used for validation of the question-
naire. For this validation we used data from 75 women,
which can be considered to be a respectable sample size.
However, lack of information on the bioavailability of
naturally occurring folates [27,28] makes data collection
regarding folate intake and its relation to folate status
challenging and can in some respects be considered as a
limitation of the study. Additionally, the 24-hour recall
interviews were performed only on weekdays, which
could have affected the collected data.
Conclusions
It can be concluded that infertile women had better
compliance to national advice on folic acid supplement
use and they consequently also had a better folate status.
Educational level and employment status were the most
significant factors related to folic acid supplement use.
Additionally, the used questionnaire for ‘usual’ use of
supplements was shown to have fair validity in regards
to folic acid supplement ‘actual’ use on the 24-hour recall
days. There was also a significantly better folate status
among the questionnaire assessed users of supplements.
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